Back

Comparing surveyed adults with long COVID and those with just a positive test helps put COVID into perspective

Adams, M.; Grandpre, J.

2024-02-03 public and global health
10.1101/2024.02.02.24302216 medRxiv
Show abstract

IntroductionAmong adults who test positive for COVID-19, some develop long COVID (symptoms lasting [&ge;]3 months), and some do not. We compared 3 groups on selected measures to help determine strategies to reduce COVID impact. MethodsUsing Stata and data for 385,617 adults from the 2022 Behavioral Risk Factor Surveillance System, we compared adults reporting long COVID, those with just a positive test, and those who never tested positive, on several health status and risk factor measures plus vaccination rates (data for 178,949 adults in 29 states). ResultsPrevalence of just COVID was 26.5% (95% CI 26.2-26.8) and long COVID was 7.4% (7.3-7.6). Compared with adults with just COVID those with long COVID had worse rates for 13 of 17 measures of chronic disease, disability, and poor health status, while those with just COVID had the best results for 15 of the 17 measures among all 3 groups. The 5 risk factors (obesity, diabetes, asthma, cardiovascular disease, and COPD) previously associated with COVID deaths, increased long COVID but not just COVID rates, which were highest among younger and higher income adults. Adults with long COVID had the highest rate among the 3 groups for any COVID risk factors and data from 29 states showed they had the lowest rates for [&ge;]3 vaccine doses of 35.6%, vs. 42.7% and 50.3% for those with just a positive test, and neither, respectively. Vaccination with [&ge;]3 vaccines vs. <3 reduced long COVID rates by 38%, and just COVID rates by 16%. ConclusionsResults show the seriousness of long COVID vs. just a positive test and that increasing vaccine coverage by targeting adults with risk factors shows promise for reducing COVID impact.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Vaccine
189 papers in training set
Top 0.2%
18.1%
2
PLOS ONE
4510 papers in training set
Top 19%
10.0%
3
BMC Public Health
147 papers in training set
Top 0.5%
6.8%
4
JAMA Network Open
127 papers in training set
Top 0.4%
6.3%
5
Preventive Medicine Reports
14 papers in training set
Top 0.1%
6.3%
6
PLOS Medicine
98 papers in training set
Top 0.8%
4.3%
50% of probability mass above
7
Vaccines
196 papers in training set
Top 0.7%
3.6%
8
JMIR Public Health and Surveillance
45 papers in training set
Top 0.9%
2.7%
9
Journal of General Internal Medicine
20 papers in training set
Top 0.4%
2.1%
10
American Journal of Preventive Medicine
11 papers in training set
Top 0.2%
2.1%
11
Frontiers in Public Health
140 papers in training set
Top 4%
1.9%
12
Clinical Infectious Diseases
231 papers in training set
Top 2%
1.9%
13
Preventive Medicine
11 papers in training set
Top 0.1%
1.7%
14
BMC Infectious Diseases
118 papers in training set
Top 3%
1.7%
15
BMJ Open
554 papers in training set
Top 10%
1.3%
16
American Journal of Epidemiology
57 papers in training set
Top 0.9%
1.3%
17
BMC Medicine
163 papers in training set
Top 5%
1.1%
18
Journal of Medical Internet Research
85 papers in training set
Top 4%
0.9%
19
International Journal of Behavioral Nutrition and Physical Activity
15 papers in training set
Top 0.4%
0.9%
20
BMJ
49 papers in training set
Top 1%
0.9%
21
International Journal of Environmental Research and Public Health
124 papers in training set
Top 6%
0.9%
22
International Journal of Public Health
17 papers in training set
Top 0.3%
0.9%
23
International Journal of Epidemiology
74 papers in training set
Top 2%
0.9%
24
Public Health
34 papers in training set
Top 2%
0.8%
25
Nature Communications
4913 papers in training set
Top 63%
0.7%
26
The Lancet Public Health
20 papers in training set
Top 0.7%
0.7%
27
EClinicalMedicine
21 papers in training set
Top 1%
0.7%
28
Pharmacoepidemiology and Drug Safety
13 papers in training set
Top 0.5%
0.7%
29
Annals of Epidemiology
19 papers in training set
Top 0.7%
0.7%
30
The Lancet Regional Health - Europe
32 papers in training set
Top 0.5%
0.7%